These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9413088)

  • 41. Antinociceptive activity of Quillaja saponaria Mol. saponin extract, quillaic acid and derivatives in mice.
    Arrau S; Delporte C; Cartagena C; Rodríguez-Díaz M; González P; Silva X; Cassels BK; Miranda HF
    J Ethnopharmacol; 2011 Jan; 133(1):164-7. PubMed ID: 20951193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.
    Fleck JD; Kauffmann C; Spilki F; Lencina CL; Roehe PM; Gosmann G
    Vaccine; 2006 Nov; 24(49-50):7129-34. PubMed ID: 16887242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen.
    So HS; Yoon HS; Choi DY; Kwon YS; Sung JH; Lee TG; Park ES; Cho HS; Lee BM; Cho JM; Ryu WS
    Mol Cells; 1997 Apr; 7(2):178-86. PubMed ID: 9163729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems.
    Sjölander S; Hansen JE; Lövgren-Bengtsson K; Akerblom L; Morein B
    Vaccine; 1996 Mar; 14(4):344-52. PubMed ID: 8744563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QS-21 and QS-7: purified saponin adjuvants.
    Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
    Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
    Skene CD; Doidge C; Sutton P
    Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral vaccination with immune stimulating complexes.
    Mowat AM; Smith RE; Donachie AM; Furrie E; Grdic D; Lycke N
    Immunol Lett; 1999 Jan; 65(1-2):133-40. PubMed ID: 10065639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
    Gilabert-Oriol R; Weng A; von Mallinckrodt B; Stöshel A; Nissi L; Melzig MF; Fuchs H; Thakur M
    Int J Pharm; 2015 Jun; 487(1-2):39-48. PubMed ID: 25839418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of cell death by saponin and antigen delivery.
    Wu CA; Yang YW
    Pharm Res; 2004 Feb; 21(2):271-7. PubMed ID: 15032308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant.
    Bengtsson KL; Sjölander A
    Vaccine; 1996 Jun; 14(8):753-60. PubMed ID: 8817821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
    Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
    Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines.
    Hong F; Xiao W; Ragupathi G; Lau CB; Leung PC; Yeung KS; George C; Cassileth B; Kennelly E; Livingston PO
    Planta Med; 2011 May; 77(8):817-24. PubMed ID: 21128203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of saponin from Quillaja saponaria (molina) on antibody, tumour necrosis factor and interferon-gamma production.
    Gebara VC; Petricevich VL; Raw I; da Silva WD
    Biotechnol Appl Biochem; 1995 Aug; 22(1):31-7. PubMed ID: 7576254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposomes and ISCOMs.
    Kersten GF; Crommelin DJ
    Vaccine; 2003 Feb; 21(9-10):915-20. PubMed ID: 12547602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quaternary structure of the immunostimulating complex (iscom).
    Ozel M; Höglund S; Gelderblom HR; Morein B
    J Ultrastruct Mol Struct Res; 1989 Dec; 102(3):240-8. PubMed ID: 2634709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Davies NM
    Int J Pharm; 2009 Jul; 376(1-2):123-33. PubMed ID: 19375488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues.
    Škalamera Đ; Kim H; Zhang P; Michalek SM; Wang P
    J Org Chem; 2020 Dec; 85(24):15837-15848. PubMed ID: 32463234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QS-21 structure/function studies: effect of acylation on adjuvant activity.
    Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR
    Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.